Visit Us
1100 NE 163rd Street, Suite 101 · North Miami Beach, FL 33162
Call Now!
(305) 834-4103

Shockwave therapy, often called extracorporeal shockwave therapy (ESWT), is a non-invasive treatment that uses focused acoustic pulses to address chronic musculoskeletal pain. In podiatry, it’s primarily used to target persistent problems in the heel, arch, and Achilles tendon where conservative measures have not delivered lasting relief. The intent is to stimulate biological repair without surgery.
Unlike injections or oral medications, shockwave therapy works by delivering mechanical energy to targeted tissues. That energy encourages local changes in circulation, reduces chronic inflammation, and can trigger processes that support collagen remodeling and tissue regeneration. For many patients, this means an alternative path toward healing that preserves structure and function.
Because it is performed in the office and typically requires no anesthesia, shockwave therapy fits well into clinic-based treatment plans. It is an adjunctive option that complements other non-surgical approaches such as physical therapy, orthotic support, and activity modification. When chosen appropriately, it can help bridge the gap between conservative care and more invasive interventions.
The core mechanism behind shockwave therapy is the delivery of high-energy acoustic waves to a precisely defined area. These pulses create microtrauma at the cellular level that jump-starts the body’s natural repair responses. This isn’t harmful tissue destruction; rather, it promotes a controlled inflammatory cascade that encourages healing in chronically stalled tissues.
At the treatment site, shockwaves increase blood flow and prompt the release of growth factors and signaling molecules that support tissue regeneration. Over time, these biochemical changes can reduce pain, improve mobility, and restore strength in tendons and the plantar fascia. The process is gradual and often becomes more noticeable after a few sessions.
Clinically, providers tailor the intensity and focus of the pulses to the condition being treated and to the patient’s tolerance. Modern devices allow precise targeting, which helps concentrate the therapeutic effect where it’s needed most while minimizing impact on surrounding structures.
Shockwave therapy is most commonly used for chronic plantar fasciitis and Achilles tendinopathy—conditions characterized by persistent localized pain and degenerative changes. These diagnoses frequently resist short-term measures like rest, stretching, and NSAIDs when the underlying tissue has become chronically inflamed or degenerated.
Beyond heel and Achilles complaints, shockwave can be useful for posterior tibial tendinopathy, peroneal tendon issues, and certain overuse injuries such as stress reactions in the foot. It may also play a role in managing stubborn areas of tendonitis or focal soft-tissue scarring that impede recovery.
While not a universal remedy, shockwave is a practical option when conservative care has plateaued and when patients prefer to avoid surgical intervention. Your clinician will assess imaging, symptoms, and functional limitations to determine whether the condition is likely to respond to this modality.
Multiple clinical studies and systematic reviews have evaluated shockwave therapy for plantar fasciitis and tendinopathies, reporting meaningful reductions in pain and improvements in function for many patients. Outcomes vary by study and patient population, but a substantial body of evidence supports its use as part of a non-surgical treatment pathway.
Improvements are typically measured over weeks to months, with some patients experiencing noticeable relief after a few treatments and continued gains over the following months. Success is influenced by factors such as symptom duration, severity, and adherence to complementary therapy recommendations like stretching and activity modification.
As with any treatment, realistic expectations and careful patient selection are important. Providers use the evidence base to guide recommendations, combining clinical judgment with patient goals to determine the best individualized approach.
When performed by a trained practitioner, shockwave therapy has a favorable safety profile. Because it is non-invasive, it avoids many risks associated with surgery, such as infection or wound complications. Common short-term effects are mild and may include transient soreness, redness, or brief discomfort at the treatment site.
Certain patients are not appropriate candidates—those with active infections, open wounds in the treatment area, or specific clotting disorders may need alternative strategies. Pregnant patients and individuals with implanted electronic devices typically require special consideration. A thorough medical history and physical exam will identify any contraindications before treatment begins.
Open communication about medication use, prior treatments, and overall health helps the clinician minimize risk and set a treatment plan that aligns with the patient’s medical profile and recovery goals.
One of the clearest advantages of shockwave therapy is that it offers a non-surgical path to address chronic soft-tissue conditions. For patients seeking to avoid the downtime and risks of operative procedures, shockwave provides a conservative but proactive option that targets the biology of healing rather than masking symptoms.
The procedure typically requires only brief in-office visits, and most patients can resume normal activities shortly afterward, adjusting intensity as needed. Because there is no incision or general anesthesia involved, recovery is generally faster and less complex than post-surgical rehabilitation.
In practice, shockwave is often integrated into a broader care plan that includes therapeutic exercises, orthotic support when appropriate, and guidance on activity progression—combining symptom relief with long-term strategies to reduce recurrence.
A typical course of shockwave therapy involves a series of brief sessions performed at regular intervals—commonly once a week over several weeks. Each session usually lasts only a few minutes at the treatment site, though total time in the office may be longer to allow assessment and setup.
Before treatment begins, the clinician will examine the foot, localize the area of greatest tenderness, and may use palpation or imaging to refine targeting. During the session, patients feel a series of pulses; sensations range from mild to moderately uncomfortable depending on tolerance and the area being treated. Many practitioners adjust energy levels to balance effectiveness with comfort.
Aftercare is straightforward: patients are advised on activity modification, stretching, and gradual return to load-bearing activities. Follow-up visits assess progress and help determine whether additional interventions or adjunct therapies are needed.
Deciding whether shockwave therapy is appropriate begins with a careful clinical evaluation. If conservative measures—such as stretching regimens, activity adjustment, bracing, or orthotics—have failed to produce lasting improvement, shockwave may be a reasonable next step to promote healing without surgery.
Shared decision-making is central: your provider will explain likely benefits, potential side effects, and how shockwave fits alongside other treatments. Factors such as symptom duration, imaging findings, and functional goals guide whether this modality is recommended as a standalone option or as part of a combined approach.
Primary Foot Care Center, Inc. offers assessment and guidance for patients considering shockwave therapy, helping individuals weigh risks and benefits and develop a personalized treatment plan that supports recovery and a return to daily activities.
In summary, shockwave therapy is a scientifically supported, office-based treatment that can help patients with persistent heel and tendon pain achieve meaningful improvement without surgery. It works by stimulating the body’s own repair mechanisms and is best considered after a thorough evaluation and trial of conservative care. If you would like to learn more about whether shockwave therapy is right for your foot or ankle condition, please contact us for further information.
Medically reviewed by Dr. Tamara Fishman, DPM Updated September 17, 2026
Shockwave therapy, also known as extracorporeal shockwave therapy (ESWT), is a noninvasive treatment that delivers focused acoustic pulses to painful areas of the foot and ankle. The procedure is performed in the office and does not require general anesthesia, making it an attractive option for patients seeking alternatives to surgery. It is commonly used when conservative measures have not produced lasting relief.
The therapeutic pulses create controlled microtrauma that stimulates a localized healing response, increasing blood flow and prompting the release of growth factors that support tissue repair. Over time this process can reduce chronic inflammation and encourage collagen remodeling in tendons and the plantar fascia. Clinicians adjust pulse intensity and targeting to match the condition and patient tolerance.
Shockwave therapy is most often recommended for chronic plantar fasciitis and Achilles tendinopathy, particularly when symptoms persist despite stretching, orthotic support, and physical therapy. It can also be considered for posterior tibial tendinopathy, peroneal tendon problems, and certain overuse injuries where focal degenerative changes are present. The modality is intended for conditions that have plateaued with conservative care rather than acute injuries.
Not every diagnosis is a good fit, and outcomes depend on factors such as symptom duration, tissue degeneration, and patient activity goals. Your clinician will review imaging and clinical findings to determine whether shockwave is likely to address the underlying pathology. When indicated, it is typically used as part of a broader, multimodal treatment plan.
A typical course of shockwave therapy involves a series of brief sessions scheduled at regular intervals, commonly once per week for several weeks depending on the device and treatment protocol. Each in-office session usually lasts only a few minutes at the targeted site while total visit time includes assessment and setup. Before treatment, the clinician will localize the area of greatest tenderness using palpation and may use imaging or diagnostic markers to refine targeting.
During the session patients feel a sequence of pulses that range from mild to moderately uncomfortable, and the provider adjusts energy levels to balance therapeutic effect and comfort. After treatment most patients can resume normal activities with sensible modifications to loading and exercise. Follow-up visits monitor progress and guide any additional interventions or adjunct therapies.
Patients commonly describe the treatment sensation as a series of tapping or pressure pulses at the treatment site that can be mildly uncomfortable but tolerable for most individuals. The practitioner may reduce intensity or use short breaks to maintain comfort while preserving effectiveness. Because anesthesia is not usually required, patients remain alert and can provide feedback during the procedure.
After a session some soreness, pinpoint tenderness, or mild swelling is normal and typically resolves within a few days. Clinicians provide guidance on activity modification, stretching, and progressive return to weight-bearing exercises to support recovery. If symptoms persist or worsen, the provider will reassess to determine next steps.
Certain patients require special consideration or alternate approaches before undergoing shockwave therapy, including those with active infections, open wounds, or known clotting disorders in the treatment area. Pregnant patients and individuals with implanted electronic devices such as pacemakers may be excluded or require consultation with their medical team. A full medical history and focused physical exam help identify contraindications and precautions.
Medications that affect bleeding or tissue healing should be discussed with the clinician, and imaging may be warranted to rule out conditions that would not benefit from ESWT. Careful patient selection reduces risk and improves the chance of meaningful clinical improvement. Shared decision-making ensures the chosen plan aligns with the patient’s health profile and recovery goals.
Multiple clinical trials and systematic reviews have found that shockwave therapy can provide meaningful pain reduction and functional improvement for many patients with chronic plantar fasciitis and tendinopathies. Outcomes vary by study design, device type, and patient population, but a substantial evidence base supports ESWT as a nonoperative option for conditions that have not responded to conservative care. Improvements are generally measured over weeks to months rather than immediately after a single session.
Success rates are influenced by symptom duration, severity, and adherence to complementary therapies such as stretching and activity modification. Providers use the available literature together with clinical judgment to set realistic expectations and tailor treatment protocols. Continued research refines indications and optimal parameters for different diagnoses.
Shockwave therapy complements other noninvasive approaches such as physical therapy, custom orthotics, activity modification, and anti‑inflammatory strategies rather than replacing them outright. Unlike injections that may temporarily reduce pain, ESWT aims to stimulate biological repair and tissue regeneration, offering a different therapeutic mechanism. In many care plans clinicians combine shockwave with therapeutic exercise and offloading to address both symptoms and contributing mechanical factors.
Compared with surgery, ESWT avoids incisions, general anesthesia, and the recovery demands of operative procedures, making it an appealing intermediate option for patients who wish to pursue healing without operative risk. The choice among therapies depends on diagnosis, prior treatments, patient preferences, and functional goals. Shared decision‑making helps determine the most appropriate sequence of interventions.
When administered by a trained clinician, shockwave therapy has a favorable safety profile and avoids many risks associated with surgical interventions. Common short‑term effects include transient soreness, mild swelling, and brief redness at the treatment site, which typically resolve within days. Serious complications are uncommon with proper patient selection and technique.
Risk is minimized through careful evaluation of medical history, review of medications, and attention to any contraindications such as infection or clotting disorders. Open communication with the treating provider about symptoms and tolerance allows adjustments to energy settings or treatment strategy as needed. If unexpected or prolonged side effects occur, the clinician will reassess and recommend appropriate care.
Selection for shockwave therapy begins with a comprehensive clinical evaluation that includes history, physical examination, and, when indicated, imaging studies to characterize the tissue pathology. Providers assess factors such as symptom duration, prior treatment response, functional limitations, and the presence of degenerative or inflammatory changes that may predict response to ESWT. This information guides whether shockwave is recommended as a standalone treatment or as part of a combined approach.
Shared decision‑making is central to the process: clinicians explain potential benefits, limitations, and alternatives so patients can weigh options against their recovery goals. If shockwave is chosen, the team outlines a treatment schedule, complementary home exercises, and follow‑up plans to monitor progress. Ongoing reassessment ensures care remains aligned with outcomes and patient expectations.
To explore whether shockwave therapy is appropriate for your foot or ankle condition, call our office at (305) 834-4103 to request an evaluation with Dr. Tamara Fishman and the clinical team. During the appointment the provider will review your medical history, perform a focused examination, and discuss prior treatments and your goals to determine the best next steps. If imaging or additional testing is needed, the staff will coordinate those studies as part of the diagnostic process.
Primary Foot Care Center, Inc. is located at 1100 NE 163rd Street, Suite 101, North Miami Beach, FL 33162, and our team can explain what to expect at your first visit and how shockwave therapy could fit into a personalized care plan. Clear communication and a tailored approach help ensure that any recommended treatment aligns with your needs and activity objectives. Please bring a list of medications and any prior imaging to the appointment to help streamline the evaluation.
Send us a message and a member of our team will get back to you shortly. For urgent concerns, please call the office directly.

Phone: